Aspirin
- Product NDC
- 0363-0157
- 11-digit product format
- 003630157
- Labeler code
- 0363
- Product ID
- 0363-0157_f0381bfa-fd3f-4242-9baf-0b84dfaa4660
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Walgreen Company
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 1996-02-10
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0363-0157 | 0363-0157-12 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 0363-0157 | 0363-0157-17 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0363-0157-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | 0363-0157-17 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0363-0157-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | 0363-0157-17 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0363-0157-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 0363-0157-17 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0363-0157-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | 0363-0157-17 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0363-0157-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | 0363-0157-17 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0363-0157-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | 0363-0157-17 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0363-0157-12 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 0363-0157-17 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0363-0157-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | 0363-0157-17 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0363-0157-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0363-0157-17 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0363-0157-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | 0363-0157-17 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0363-0157-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 0363-0157-17 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0363-0157-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 0363-0157-17 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aspirin
- Brand name suffix
- Regular Strength
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 212033 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0363-0157-12 | AspirinRegular Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 18 | |
| 0363-0157-12 | AspirinRegular Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 18 | |
| 0363-0157-14 | AspirinRegular Strength | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 18 | |
| 0363-0157-17 | AspirinRegular Strength | 300 in 1 BOTTLE | TABLET, FILM COATED | 300 | 18 | |
| 0363-0157-98 | AspirinRegular Strength | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0363-0157-12 | EA - Each | 0363-0157 | c1df263e-160b-44c3-846e-1b47026abbd2 | 1 | 2013-07-02 |
| 0363-0157-14 | EA - Each | 0363-0157 | 3fa3e4c3-88ca-4555-ac59-97f896a4ff49 | 1 | 2013-07-02 |
| 0363-0157-17 | EA - Each | 0363-0157 | 9be46883-8972-492d-8925-4fcbd1e7cd21 | 1 | 2013-07-02 |
| 0363-0157-98 | EA - Each | 0363-0157 | 71183431-ecba-4ae7-a730-70e6729f3f60 | 1 | 2015-07-20 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ASPIRIN REGULAR STRENGTH (ASPIRIN) TABLET, FILM COATED [WALGREEN CO.] | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | Aurohealth LLC | 30756257-f748-4a5d-b031-dd267d0f91ad | 2023-11-29 | Warnings | M013 |
| Aurophen Regular Strength | ACETAMINOPHEN | Aurohealth LLC | 8eda893f-5266-4b7a-95b9-2e194973cf06 | 2023-11-29 | Warnings | M013 |
| Childrens Pain Relief | ACETAMINOPHEN | Aurohealth LLC | 00ec6518-b5e3-49d1-a342-139381c3bfd2 | 2023-11-29 | Warnings | M013 |
| CHILDRENS PAIN RELIEF | ACETAMINOPHEN | Better Living Brands, LLC | fadb4c09-071f-56c0-e053-6294a90ae6c1 | 2023-11-28 | Warnings | M013 |
| Acetaminophen and Diphenhydramine hydrochloride | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | Better Living Brands, LLC | fc07d516-9ffe-9989-e053-6294a90ae1a5 | 2023-11-28 | Warnings | M013 |
| NOTTS - Tension Headache | ACETAMINOPHEN, CAFFEINE | VIVUNT PHARMA LLC | 08f2ae03-967b-ad7e-e063-6294a90a8484 | 2023-11-24 | Warnings | M013 |
| Sanatos Multi Symptoms Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0a60326a-a17b-e843-e063-6394a90ac211 | 2023-11-22 | Warnings | M013 |
| Sanatos Nighttime Multi Symptoms | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Pharmadel LLC | 0ab188f3-f7f9-d665-e063-6294a90a198a | 2023-11-22 | Warnings | M013 |
| ASPIRIN | ASPIRIN | TIME CAP LABS INC | fe12519c-3e5f-4592-bd34-2d6b81b981f4 | 2023-11-22 | Warnings | M013 |
| Rugby Regular Strength Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 400d4a29-9e39-4e74-8272-37be5d789924 | 2023-11-22 | Warnings | M013 |
| RIGHT REMEDIES Pain Relief Extra Strength Caplet | ACETAMINOPHEN | Strive Pharmaceuticals Inc. | dcce28d9-8528-489e-b995-1d98e9d0e6ad | 2023-11-21 | Warnings | M013 |
| Sanatos Multi Symptom Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCI | Pharmadel LLC | 0ab11691-5b29-55fc-e063-6394a90aa328 | 2023-11-17 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | A-S Medication Solutions | 1e223faa-f6d0-4235-bc4c-6cfca84a5b0a | 2023-11-17 | Warnings | M013 |
| SanaTos X | ACETAMINOPHEN, DEXTROMETHORPHAN HBR,GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | 85b8ef3d-7318-7f3b-e053-2991aa0a0777 | 2023-11-14 | Warnings | M013 |
| RIGHT REMEDIES EXTRA STRENGTH PM Pain Relief | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Strive Pharmaceuticals Inc. | 8badbaad-eb35-4251-a779-00474819360d | 2023-11-13 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Trifecta Pharmaceuticals USA LLC | 09935a74-34b0-0e7c-e063-6294a90a7c83 | 2023-11-07 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | AMERIFOODS TRADING COMPANY | f6dd6396-93e9-1096-e053-6394a90af06d | 2023-11-02 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | RETAIL BUSINESS SERVICES , LLC. | eb644e9e-36dc-5f84-e053-2a95a90affa5 | 2023-11-02 | Warnings | M013 |
| Good Sense Childrens Pain and Fever | ACETAMINOPHEN | Proficient Rx LP | 46527b1f-7515-44ce-b5cb-9d24223b9af1 | 2023-11-01 | Warnings | M013 |
| Aspirin | ASPIRIN | A-S Medication Solutions | 12feb32b-4b8c-4b17-9e86-cb286457b088 | 2023-11-01 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
| 212033 | ASA 325 MG Oral Tablet | SY | 0b27c0fd-7ea8-4588-9169-5ad4e8df77ef | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0363-0157-12 | 00363015712 | 1 BOTTLE in 1 CARTON (0363-0157-12) > 100 TABLET, FILM COATED in 1 BOTTLE | 1 bottle | 1996-02-10 | 2021-03-19 | No | No | Current |
| 0363-0157-14 | 00363015714 | 500 TABLET, FILM COATED in 1 BOTTLE (0363-0157-14) | 1996-02-10 | 0000-00-00 | No | No | Current | |
| 0363-0157-17 | 00363015717 | 300 in 1 BOTTLE | Historical | |||||
| 0363-0157-98 | 00363015798 | 100 TABLET, FILM COATED in 1 BOTTLE (0363-0157-98) | 1996-02-10 | 0000-00-00 | No | No | Current |